Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

Grants

Funding Acknowledgements

The scientific development and funding for this project were funded by the following: NIH R01 CA-1491429 (Phelan PI); the US National Cancer Institute (R01-CA076016); the COGS project is funded through a European Commission's Seventh Framework Programme grant (agreement number 223175 HEALTH F2 2009-223175); the Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative (U19-CA148112); the Ovarian Cancer Association Consortium is supported by a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). Investigator-specific funding: G.C.-T. is supported by the National Health and Medical Research Council; B.K. is funded by the American Cancer Society Early Detection Professorship (SIOP-06-258-01-COUN) and the National Center for Advancing Translational Sciences (NCATS), Grant UL1TR000124; L.E.K. is supported by a Canadian Institute of Health Research New Investigator Award (MSH-87734). Funding of included studies: Funding of the constituent studies was provided by the California Cancer Research Program (00-01389V-20170, N01-CN25403, 2110200); the Canadian Institutes of Health Research (MOP-86727); Cancer Australia; Cancer Council Victoria; Cancer Council Queensland; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; the Cancer Institute of New Jersey; Cancer Research UK (C490/A6187, C490/A10119, C490/A10124); the Danish Cancer Society (94-222-52); the ELAN Program of the University of Erlangen-Nuremberg; the Eve Appeal; the Helsinki University Central Hospital Research Fund; Helse Vest; the Norwegian Cancer Society; the Norwegian Research Council; the Ovarian Cancer Research Fund; Nationaal Kankerplan of Belgium; Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy For Cancer Control from the Ministry of Health Labour and Welfare of Japan; the L & S Milken Foundation; the Polish Ministry of Science and Higher Education (4 P05C 02814, 2 P05A 068 27); the Roswell Park Cancer Institute Alliance Foundation; the US National Cancer Institute (K07-CA095666, K07 CM 43047, K22-CA138563, N01-CN55424, N01-PC67001, N01-PC067010, N01-PC035137, P01-CA017054, P01-CA087696, P01-CA087969, CA072720, P50-CA105009, P50-CA136393, P30-R01CA014089, R01-CA016056, R01-CA017054, R01CA049449, R01-CA050385, R01-CA054419, R01CA058598, R01-CA058860, R01-CA061107, R01CA061132, R01-CA067262, R01-CA071766, R01CA074850, R01-CA080742, R01-CA080978, R01CA083918, R01-CA087538, R01-CA092044, 801095023, R01-CM 22443, R01-CA112523, R01CA114343, R01-CA126841, R01-CA136924, R03 CM 13148, R03-CM 15195, U01-CA069417, U01CA071966, UM1-CM 82910, UM 1-CM 86107 and Intramural research funds); the US Army Medical Research and Material Command (DAMD17-01-10729, DAMD17-02-1-0666, DAM D17-02-1-0669, W81XWH-07-0449, W81XWH-10-1-02802); the US Public Health Service (PSA-042205); The National Health and Medical Research Council of Australia (199600 and 400281); the German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research (01GB 9401); the State of Baden-Wurttemberg through Medical Faculty of the University of Ulm (P.685); the Minnesota Ovarian Cancer Alliance; the Mayo Foundation; the Fred C. and Katherine B. Andersen Foundation; the Lon V. Smith Foundation (LVS-39420); the Oak Foundation; the OHSU Foundation; the Mermaid I project; the Rudolf-Bartling Foundation; the UK National Institute for Health Research Biomedical Research Centres at the University of Cambridge, Imperial College London, University College Hospital "Womens Health Theme" and the Royal Marsden Hospital; WorkSafeBC.